MATTHEW MARSHALL: Open Payments
NPI 1073925319 · BRANSON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$524 in 26 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $524
Food & beverage: $524
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $170 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $110 |
| Axsome Therapeutics, Inc. | 3 | $75 |
| Radius Health, Inc. | 2 | $42 |
| Globus Medical, Inc. | 1 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $22 |
| Exact Sciences Corporation | 1 | $20 |
| Lundbeck LLC | 1 | $16 |
| Merck Sharp & Dohme LLC | 1 | $15 |
Products named: FARXIGA, CAPLYTA, Auvelity, AIRSUPRA, Tymlos, REXULTI, Senza, ZEPBOUND.
Industry payments across MO — which companies pay providers there.
